Ishita Drugs And Industries (BOM:524400) 10-Year Sharpe Ratio: 0.44 (As of Jun. 24, 2026)


BOM:524400 Ishita Drugs And Industries Ltd BOM:524400
73 GF Score
Price ₹77.17
GF Value ₹77.99
Valuation Fairly Valued
! 3 Warning Signs
View Full Analysis

What is Ishita Drugs And Industries 10-Year Sharpe Ratio?

Ishita Drugs And Industries BOM:524400 +7.93% 73 10-Year Sharpe Ratio is 0.44 as of Jun. 24, 2026. GuruFocus rates BOM:524400 with a GF Score™ of 73/100 and a GF Value™ of ₹77.99 (Fairly Valued). The stock has 3 warning signs investors should review.

The 10-Year Sharpe Ratio measures the additional return that an investor receives per unit of increase in risk over the past ten years. As of today (2026-06-24), Ishita Drugs And Industries's 10-Year Sharpe Ratio is 0.44.

Ishita Drugs And Industries  (BOM:524400) 10-Year Sharpe Ratio Explanation

The 10-Year Sharpe Ratio inidicates the risk-adjusted return of an investment over the past ten years. It is calculated as the annualized result of the average ten-year monthly excess returns divided by its standard deviation in the ten-year period. The monthly excess return is the monthly investment return minus the monthly risk-free rate (typically the 10-year Treasury Constant Maturity Rate). If the risk-free rate for a specific region is not available, U.S. data is used by default.

The greater a portfolio's Sharpe Ratio, the better its risk-adjusted performance. A negative Sharpe Ratio means the risk-free rate is greater than the portfolio’s historical or projected return, or else the portfolio's return is expected to be negative.

Ishita Drugs And Industries 10-Year Sharpe Ratio Related Terms

BOM:524400 vs ZTS: 10-Year Sharpe Ratio Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Ishita Drugs And Industries's 10-Year Sharpe Ratio, along with its competitors' market caps and 10-Year Sharpe Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Ishita Drugs And Industries 10-Year Sharpe Ratio vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Ishita Drugs And Industries's 10-Year Sharpe Ratio distribution charts can be found below:

* The bar in red indicates where Ishita Drugs And Industries's 10-Year Sharpe Ratio falls into.


BOM:524400
73GF Score
Ishita Drugs And Industries Ltd BOM:524400
10-Year Sharpe Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Ishita Drugs And Industries 10-Year Sharpe Ratio Calculation

The 10-Year Sharpe Ratio measures the performance of an investment such as a stock or portfolio compared to a risk-free asset in the last ten years. A stock / portfolio's 10-Year Sharpe Ratio can be calculated by dividing the difference between the ten-year average monthly returns of the investment and the risk-free rate, by the standard deviation of the investment returns over the past ten years.

Frequently Asked Questions Learn more about 10-Year Sharpe Ratio →
What does a 10-Year Sharpe Ratio of 0.44 mean?
Ishita Drugs And Industries (BOM:524400) has a 10-Year Sharpe Ratio of 0.44 as of Jun. 24, 2026. 10-Year Sharpe Ratio measures the additional return that an investor receives per unit of increase in risk over the past ten years. View historical data for Ishita Drugs And Industries and its competitors.
Is Ishita Drugs And Industries' 10-Year Sharpe Ratio too high?
Ishita Drugs And Industries' current 10-Year Sharpe Ratio is 0.44. Overall, Ishita Drugs And Industries has a GF Score™ of 73/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Ishita Drugs And Industries' 10-Year Sharpe Ratio compare to ZTS?
Ishita Drugs And Industries' 10-Year Sharpe Ratio of 0.44 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 10-Year Sharpe Ratio for a Drug Manufacturers company?
A good 10-Year Sharpe Ratio depends on the Drug Manufacturers industry context. However, 10-Year Sharpe Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 10-Year Sharpe Ratio mean?
A high 10-Year Sharpe Ratio can signal that a stock is expensive relative to its fundamentals. 10-Year Sharpe Ratio measures the additional return that an investor receives per unit of increase in risk over the past ten years. View historical data for Ishita Drugs And Industries and its competitors. Ishita Drugs And Industries's current 10-Year Sharpe Ratio is 0.44. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Ishita Drugs And Industries stock overvalued right now?
Based on GuruFocus' analysis, Ishita Drugs And Industries (BOM:524400) is currently considered Fairly Valued. The stock's GF Value™ is ₹77.99, compared to a current price of ₹77.17 — trading 1.1% below its estimated fair value. The current 10-Year Sharpe Ratio is 0.44. Ishita Drugs And Industries' overall GF Score™ is 73/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 10-Year Sharpe Ratio calculated?
10-Year Sharpe Ratio is calculated from a company's financial statements. For Ishita Drugs And Industries (BOM:524400), the current 10-Year Sharpe Ratio is 0.44 as of Jun. 24, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Ishita Drugs And Industries (BOM:524400) Overvalued in 2026?

Based on GuruFocus' analysis, Ishita Drugs And Industries stock appears to be undervalued. The current stock price of ₹77.17 is trading 1.1% below its estimated GF Value™ of ₹77.99. GuruFocus considers Ishita Drugs And Industries to be Fairly Valued.

Key valuation signals for BOM:524400:

  • 10-Year Sharpe Ratio: 0.44
  • GF Value™: ₹77.99 vs. price of ₹77.17 (1.1% below fair value)
  • GF Score™: 73/100 with 3 warning signs

No single metric tells the full story. See the BOM:524400 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Ishita Drugs And Industries Business Description

Address C.G. Road, 401, 3rd Eye -II, Opposite Parimal Garden, Ahmedabad, GJ, IND, 380006
Ishita Drugs And Industries Ltd is engaged in the business of manufacturing various APIs and drug intermediates. The company supplies its products to various pharmaceutical companies and is also being exported to various countries across the world. The company has three manufacturing facilities located in the state of Gujarat, two for APIs and drug intermediates at Ahmedabad and Surendranagar, and one for finished pharmaceutical formulations at Mehsana.
73GF Score

Get the complete analysis for BOM:524400

10-Year Sharpe Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹77.17
Price
₹77.99
GF Value